Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Corem divests properties in Västerås, Borås and Hallstahammar for SEK 420 million

In three separate transactions, Corem has signed contracts to divest the properties Västerås Köpmannen 5, Borås Bromsen 3, Borås Bromsen 4, Borås Spindeln 13 and Borås Spindeln 14 as well as the site leasehold to Hallstahammar Nickeln 2 for a total underlying property value of SEK 420 million.The total lettable area amounts to approximately 41,000 sq.m. and primarily consists of retail premises.”The divestments are an additional step in the streamlining of Corem and reallocation to more prioritized segments and growth”, says Peeter Kinnunen, Head of Transactions at Corem.Transfer of

Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability Data

Lund, Sweden, December 16, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going clinical Phase I trial with the 4-1BB (CD137) drug candidate ATOR-1017, which is developed as a tumor-directed therapy for metastatic cancer. The early readout data corroborates previous data on biomarkers, safety and tolerability, sustaining a safety profile up to and including a dose of 360 mg with no dose limiting toxicities reported. The Phase I study with ATOR-1017 is a first-in-human, open-label, dose escalation study in patients with advanced solid cancer (

AFRICA OIL CHAIRMAN'S LETTER TO SHAREHOLDERS

VANCOUVER, BC, December 16, 2021 /CNW/ - Africa Oil Corp. (AOI – TSX, Nasdaq Stockholm) … Chairman of the Board, John Craig publishes a letter to the shareholders. Dear Africa Oil shareholders, I am pleased to write to you as we near end of 2021, a very strong year for your company. Our success is underpinned by our investment in Prime Oil and Gas Cooperatief UA (“Prime”). With its strong production and cash flow performance, Prime has served us very well during the most volatile and challenging period for the industry. Your Board of Directors continue to be very positive on this

Important step taken for Balder’s first apartments in “Framtidens Backaplan”

The vision for Framtidens Backaplan is ambitious and the urban development project is now taking the next big step – in January, the zoning plan for the western part of the area, Zoning plan 2 Backaplan, will go out for consultation. In this part of the area, the property company Balder is planning four residential blocks and an office property. The ambition is that the first apartments will be ready for occupation in 2025.On Tuesday, 14 December, the building committee in Gothenburg decided to take the next step in the urban development project Framtidens Backaplan and allow zoning plan 2

BICO invites to a teleconference about the acquisition of Biosero

BICO invites to a presentation, later today, December 16, to inform about the acquisition of Biosero during two different occasions to be able to, from a time zone perspective fit both the European and the US investor base. Biosero is a San Diego based company, with 75 employees globally and founded in 2003. The company offers software solutions, under the umbrella of Green Button Go and services which enable seamless laboratory automation for connected and smart workflows. · The presentation will focus on the rationale of the acquisition, presentation of Biosero and synergies going

Flexion Mobile launches Puzzles & Survival

Top developer adds platforms and revenue with FlexionLONDON, 16th of December, 2021 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has launched Puzzles & Survival in Amazon App Store and Samsung Galaxy Store. The game already generates around USD 16 million on Google Play according to Sensor Tower data from November 2021. Flexion’s distribution services will add revenue from the alternative platforms with little work being required of 37Games. Flexion is currently averaging around 10% extra revenue for Android games it distributes. “

Sitowise Group Plc issues 250,000 new shares without consideration to the company itself in a directed issue

Sitowise Group Plc Stock Exchange Release 16 December 2021 at 9:00 am (EET) Sitowise Group Plc issues 250,000 new shares without consideration to the company itself in a directed issue On 15 December 2021, the Board of Directors of Sitowise Group Plc ("Sitowise") has decided, by virtue of the authorisation granted by the unanimous resolution of the shareholders on 3 March 2021, to issue in a directed issue 250,000 new Sitowise shares (the "Shares") to Sitowise itself without consideration. The number of Shares issued in the share issue (the "Share Issue") corresponds to approximately

Samhällsbyggnadsbolaget i Norden AB acquires homes for SEK 423m from the municipal real estate company HFAB

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) acquires seven rent regulated residential properties in Halmstad from the municipal real estate company HFAB. The property portfolio consists of a total lettable area of approximately 15,000 sq.m. and the number of apartments amounts to 175, the majority of which are located in central Halmstad. SBB already owns community service properties of 53,000 sqm in Halmstad and through this acquisition, SBB expands to also offer housing in the area. "SBB makes its second municipal deal in December and we are pleased with the trust we have

Glen Instone appointed President Husqvarna Division

Glen Instone has been appointed President of the Husqvarna Division within Husqvarna Group. He will continue to serve as the Group CFO until his successor is appointed. "I am very pleased to see Glen become the President of the Husqvarna Division, a role he has been successfully leading since July, combined with his CFO role. His broad experience and knowledge about our company combined with his leadership skills will be of great value to further strengthen and grow the Husqvarna Division” says Henric Andersson, President & CEO Husqvarna Group. Since joining Husqvarna in 2002,

Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network.

Stockholm, Sweden and New York, US, - December 16, 2021 - SciBase Holding AB  ("SciBase") [STO:SCIB], a leader of augmented intelligence-based solutions for skin disorders, announced today that it has received an order of ten additional Nevisense systems and electrodes valued at approximately KUSD 100 from Advanced Dermatology, P.C. ("AdvDermPC") in New York City.AdvDermPC is one of the largest dermatology groups in the New York City tri-state area with 59 practices.  This order brings the total number of AdvDermPC practices utilizing Nevisense to seventeen.

Peab acquires property in Borås

Peab has signed a contract with Corem for the acquisition of the mall Knallerian with four properties in the commercial area Knalleland in Borås for an underlying property value of SEK 110 million. There is a positive zoning plan decision concerning development of the area.Peab has acquired the mall Knallerian with four properties and a total area of 15,165 m2 in the commercial area Knalleland. The leasable space is close to 23,000 m2 and currently has around 40 tenants. There is a positive zoning plan decision concerning development of the area and Borås has marked it as a focus zone

Murgröna Holding completes the recommended public offer to the shareholders of ICA Gruppen and extends the acceptance period

THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, CHINA, HONG KONG, JAPAN, MEXICO, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SWITZERLAND) WHERE THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE IN CONFLICT WITH ANY APPLICABLE LAWS OR REGULATIONS. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCE FORMS WILL NOT BE ACCEPTED FROM OR ON BEHALF OF) PERSONS WHOSE PARTICIPATION IN THE OFFER WOULD REQUIRE THAT ANY OFFER DOCUMENTS ARE PREPARED, FILINGS ARE EFFECTUATED OR OTHER MEASURES

BICO has entered into an agreement to acquire Biosero, a leading software provider for automated workflows and laboratory connectivity

The addition of Biosero’s software capabilities brings immediate synergies and will allow BICO to offer its customers fully automated and connected workflow solutions using the combination of technologies and products from current portfolio companies together with Biosero’s software solutions. In the short to mid-term, these cross-business synergies have the potential to unlock large orders related to automated workflows. BICO will also invest 20 MUSD over a three-year period to further accelerate Biosero’s commercial agenda to expand to new geographical markets and to fully monetize on

BerGenBio announces exclusive in-license of key intellectual property rights from UT Southwestern Medical Center

In-Licensing further strengthens intellectual property estate for the treatment of Non-Small Cell Cancer (NSCLC) patients with STK11 mutations  Bergen, Norway, 16 December 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announced  today the licensing of certain intellectual property from the UT Southwestern Medical Center.  The exclusive license to intellectual property generated by researchers at UT Southwestern Medical Center supports the Company's existing IP position underlying use

Nordic Nanovector appoints Experienced International Life Sciences Executive Sandra Jonsson as Chief Operating Officer

Oslo, Norway, 16 December 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces the appointment of Sandra Jonsson, PhD, MBA as Chief Operating Officer. Dr Jonsson will start on 10 January 2022 and takes over from Marco Renoldi, MD, who is retiring from the role but will remain as a consultant to the company. Dr Jonsson is a results-driven international Life Science executive, with >15 years of cross-functional experience in global pharmaceutical and biotechnology companies.

Assemblin signs national service agreement for Vattenfall’s nuclear power plants

Assemblin is delighted to announce the renewal of its framework agreement to supply maintenance, servicing and installation services to Forsmarks Kraftgrupp AB and Ringhals AB.The nationwide agreement covers electrical, instrument and mechanical maintenance for the period 2022–2024. The agreement will meet Vattenfall’s need for maintenance services at its nuclear power plants in Forsmark and Ringhals, as well as other nuclear-related operations in the Nordic region, such as the decommissioning of nuclear power plants, management of radioactive waste and spent nuclear fuel and new

Green Landscaping Group continues its establishment in Finland through the acquisition of the landscaping company Viherpojat Oy

16 December 2021, 07:00 CET Green Landscaping Group AB (publ) has acquired Viherpojat Oy with a turnover of approximately EUR 4 million. The acquisition is the second in Finland and another step on the way to establish a platform of entrepreneurial quality companies in Finland.Viherpojat is a reputable company with a long history in the landscaping industry in the Helsinki area and delivers projects to construction companies, the public sector and housing companies. The company has sales of approximately EUR 4 million and 25 employees. - We are pleased that Viherpojat joins the group

Lehto Group Plc: Mr Tero Karislahti appointed as Executive Vice President of the Housing Service Area

Lehto Group PlcStock exchange release16 December 2021 at 8.00 (a.m.)Mr Tero Karislahti, 39, has been appointed as Executive Vice President of the Housing Service Area and as a member of Lehto Group’s Executive Board as of 10 June 2022. Karislahti has a master's degree in engineering and 18 years of work experience in various positions at the construction group YIT. Since 2015, Karislahti has worked in management positions in housing construction, including as regional director.“With Tero Karislahti, the company will obtain more excellence in the field of housing construction. He

Aquaporin wins a pilot for an energy efficient solution to China’s leachate overflow

The Danish water technology company Aquaporin has won a strategic order in China to help a landfill meet the country’s strict discharge limits by treating leachate more efficiently.Managing leachate discharge in China In the first half of 2022, the landfill will receive an advanced containerized pilot system developed by Aquaporin in collaboration with Gradiant Environmental Technology to provide a sustainable and economical solution for treating landfill leachate. Aquaporin is currently involved in similar pilot projects in Southern China and Europe with the purpose of testing the

For IBS, specific diets are less important than expected

Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms. The researchers did find that a certain type of carbohydrate called ‘fodmaps’ can aggravate intestinal problems, however, the overall results indicate that they also have less influence than previously thought.“IBS is a very complex disease involving many factors, but our results indicate that the effects of specific diets

Embracer Group successfully completed a directed issue of 69,000,000 new B shares raising proceeds of roughly SEK 6 billion

INSIDE INFORMATION: Embracer Group AB (the "Company" or “Embracer Group”) has, as announced in its press release on December 15, 2021, carried out an issue of 69,000,000 new B shares directed to Swedish and international institutional investors, resolved upon by the Board of Directors based on the authorization from the annual general meeting on September 16, 2021 (the "Share Issue"). The subscription price in the Share Issue is SEK 87 per B share and has been determined through an accelerated book-building procedure led by Nordea Bank Abp, filial i Sverige, HSBC Continental Europe,

Getinge reinvents office work in the South Asia Pacific region

As a trailblazer within remote working, the global medtech company Getinge’s implementation of a long-term flexible workplace approach in the South Asia-Pacific (SAPAC) region has been a success. The acceptance rate among employees is over 90 per cent in the markets that have already implemented the concept.What started as a health and safety measurement in the early days of the COVID-19 outbreak, has turned into an established way of working in Getinge’s worldwide organization, with the objective to offer employees with position eligible for remote work a possibility to choose flexibility.

The exercise price for the warrants of series TO1 in GET Group AB (publ) has been determined to approximately SEK 0.104

GET Group AB (publ) (”GET Group” or the ”Company”) completed during December 2020 an rights issue of units consisting of one (1) new share and one (1) free of charge warrant of series TO1. In total, 41,008,175 warrants of series TO1 was issued. Each warrant entitles the holder to subscribe for one (1) new share in the Company during the period from and including 16 December 2021 to and including 30 December 2021. The exercise price per share is to be determined to 70 percent of the volume-weighted average price in the Company’s share on NGM Nordic SME during the measurement period from and

Braeburn receives new Complete Response Letter for Brixadi in the US

Lund, Sweden — 15 December 2021 — Camurus AB (NASDAQ STO: CAMX) today announced that its US licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for its updated New Drug Application (NDA) for Brixadi™ (buprenorphine) extended-release injections for the treatment of opioid use disorder. The CRL is a result of continued quality related deficiencies at Braeburn’s US based third party manufacturer, identified by the FDA during a pre-approval inspection. “We are very disappointed to learn of the new Complete Response Letter for Brixadi

There are no items matching the current filter
There are no more items matching the current filter
Back to top